Your browser doesn't support javascript.
loading
Effects of Different Immunosuppressive Drugs on Incretins in Renal Transplant Patients.
Yilmaz, Nusret; Sari, Ramazan; Suleymanlar, Gultekin; Ozdem, Sebahat.
Afiliação
  • Yilmaz N; Akdeniz University, School of Medicine, Division of Endocrinology, Antalya, Turkey.
  • Sari R; Akdeniz University, School of Medicine, Division of Endocrinology, Antalya, Turkey. Electronic address: drsari@hotmail.com.
  • Suleymanlar G; Akdeniz University, School of Medicine, Division of Nephrology, Antalya, Turkey.
  • Ozdem S; Akdeniz University, School of Medicine, Department of Biochemistry, Antalya, Turkey.
J Natl Med Assoc ; 112(3): 250-257, 2020 Jun.
Article em En | MEDLINE | ID: mdl-32305124
ABSTRACT

BACKGROUND:

Immunosuppressive drugs used in transplantation patients, may contribute to the development of post-transplant diabetes mellitus through their possible adverse effects on incretins. We aimed to compare the effects of different immunosuppressive drugs used in renal transplantation patients on glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) levels. PATIENTS AND

METHODS:

Forty five subjects were enrolled in the study (cyclosporine-treated 15 and tacrolimus-treated renal transplant patients 15, and healthy volunteers as a control group 15). Oral glucose tolerance test with 75 gr glucose was performed. GLP-1 and GIP levels were measured at 0 (baseline), 30, 60, 90, 120 min using ELISA method.

RESULTS:

A statistically significant level of difference was detected in GLP-1 levels at the baseline, 30th and 120th minutes among all three groups (p < 0,001, p = 0,026 and p = 0,022, respectively). Baseline GLP-1 levels in cyclosporine-treated renal transplant patients were higher than in both tacrolimus-treated renal transplant patients (p = 0,016) and control groups (p < 0,001). GLP-1 levels at the 30th minute were higher in tacrolimus-treated renal transplant patients when compared to the cyclosporine-treated renal transplant patients (p = 0,024). GLP-1 levels at the 120th minute were higher in tacrolimus-treated renal transplant patients than the control group (p = 0,024). The areas under the curve of GLP-1 was higher in tacrolimus-treated renal transplant patients when compared to the control group (p = 0,018). GIP levels at 120th was lower in cyclosporine-treated renal transplant patients when compared to control group (p = 0,003).

CONCLUSION:

These findings showed a temporally affected incretin hormones in renal transplant patients, a preserved GLP-1 response to an oral glucose load in renal transplant patients on cyclosporine and increased GLP -1 response to an oral glucose load in those on tacrolimus.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polipeptídeo Inibidor Gástrico / Transplante de Rim / Tacrolimo / Ciclosporina / Peptídeo 1 Semelhante ao Glucagon / Incretinas / Imunossupressores Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Humans Idioma: En Revista: J Natl Med Assoc Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Polipeptídeo Inibidor Gástrico / Transplante de Rim / Tacrolimo / Ciclosporina / Peptídeo 1 Semelhante ao Glucagon / Incretinas / Imunossupressores Tipo de estudo: Etiology_studies / Observational_studies Limite: Adult / Humans Idioma: En Revista: J Natl Med Assoc Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Turquia